ARPA-H: New Health Research Agency Faces Old Concerns About Disrupting Private Investment
Executive Summary
Proposed Advanced Research Project Agency for Health also needs to distinguish itself from NCATS, which faced many of the same questions when it was created a decade ago. Disagreements also persist about whether ARPA-H should be housed in NIH or HHS.
You may also be interested in...
NIH Biomedical Research Appropriations In 2024: US House, Senate Bills Nearly $5bn Apart
The US health research agency's budget disparities won’t be the only challenge to compromise between the two chambers on HHS appropriations. The House legislation includes several provisions on hot-button social issues that the Democratic-controlled Senate will find hard to accept.
US FDA and ARPA-H: Woodcock Has Questions
The FDA’s principal deputy commissioner wonders how the agency will work with ARPA-H to help get its projects to patients and the health care system given its other responsibilities.
Appropriators Continue Pressing US FDA To Conduct Surprise In-Person Inspections
Omnibus package also gives FDA expanded authority over nicotine products and creates President Biden’s Advanced Research Projects Agency for Health.